§ Mr. Barker
To ask the Secretary of State for Health what plans he has to introduce human papilloma virus screening to test for cervical cancer. 
Health authorities with radiotherapy centres located within its boundaries Area Cambridgeshire Addenbrooke's NHST Norfolk Norfolk and Norwich University Hospital NHST North Essex Essex Rivers Healthcare NHST South Essex Southend Hospital NHST Suffolk Ipswich Hospital NHST Hertfordshire West Hertfordshire Hospitals MHST Barking and Havering Barking Havering and Redbridge Hospitals NHST Barnet Enfield and Haringey North Middlesex University Hospital NHST Camden and Islington (2) Royal Free Hampstead NHST University College London Hospitals NHSTCH Ealing Hammersmith and Hounslow Hammersmith Hospitals NHST East London and the City Barts and the London NHST Kensington Chelsea and Westminster Royal Marsden NHST Lambeth Southwark and Lewisham Guys and St. Thomas' Hospital Trust Manchester Christie's Hospital NHST North-west Lancashire Preston Acute Hospitals NHST Wirral Clatterbridge Centre for Oncology NHST East Riding and Hull Hull and East Yorkshire Hospitals NHST Leeds Leeds Teaching Hospitals NHST Newcastle and North Tyneside The Newcastle upon Tyne Hospitals NHST North Cumbria North Cumbria Acute Hospitals NHST Tees South Tees Hospitals NHST
§ Yvette Cooper
As yet, there is insufficient evidence to support the use of human papilloma virus (HPV) testing as a primary screening tool. The health technology assessment (HTA) review of research into HPV testing, published in September 1999, concluded that the evidence might support testing for HPV only in certain situations, such as the management of borderline screening test results.
A Government funded pilot study of HPV and liquid based cytology testing as triage for women with mild or borderline abnormalities began in April 2001. The HPV arm of the pilot will end in September 2002. Analysis of the data will begin in October 2002 and a report of the evaluation of the pilot will be submitted in early 2003.